Altered Cytokine Production in Atopic Dermatitis: A Preliminary Study
- 1 January 1993
- journal article
- research article
- Published by Mary Ann Liebert Inc in Pediatric Asthma, Allergy & Immunology
- Vol. 7 (2) , 127-133
- https://doi.org/10.1089/pai.1993.7.127
Abstract
Infiltrating lymphocytes in skin lesions from patients with atopic dermatitis are capable of secreting a variety of interleukins (IL) that may promote IgE synthesis, IL-4, or decrease interferon-gamma (γIFN) production. Previous studies conducted in atopic patients have revealed a direct correlation between serum IgE, IL-4 and an inverse relationship with γIFN levels. We investigated the role of cellular and serum -γIFN, serum IL-4, and IgE levels in 7 patients, 5 adults and 2 children (mean age 20.3 years) with atopic dermatitis. During the study, none of the patients were treated with systemic steroids or other immunosuppressive therapy. We demonstrated that clinical scoring for associated asthma, rhinitis, or gastrointestinal complaints best coincided with IgE levels. However, a slight trend of serum IgE levels with IL-4 was noted in 3 patients. Baseline (0.4 ± 0.9 pg/mL) and mitogen-stimulated (1.4 ± 1.0 pg/mL) peripheral blood mononuclear cell (PBMC) γIFN production was detected in 5 of 7 patients, but mitogen-stimulated levels were higher in nonatopic controls (9.5 pg/mL). Elevated serum -γIFN levels at 52 pg/mL were observed compared to nonatopic controls at 6 pg/mL. In 6 of 7 patients with elevated serum γIFN levels, an inverse correlation was noted in 4 patients with low serum IL-4 levels. Elevated levels of serum IL-4 were observed in 3 of 7 patients, with undetectable levels in another 3 patients. Mitogen- or antigen-stimulated cellular PBMC IL-4 levels were also detected in 3 patients with elevated serum IL-4, but less cellular γIFN was noted compared to normal controls. There was no correlation between any interleukin levels and a clinical score for associated atopic conditions. In conclusion, our preliminary study demonstrated that cellular and humoral IL-4 and γIFN production can be dysregulated in certain patients with atopic dermatitis, which can enhance IgE synthesis.Keywords
This publication has 22 references indexed in Scilit:
- Evidence suggesting involvement of interleukin-4 (IL-4) production in spontaneous in vitro IgE synthesis in patients with atopic dermatitisJournal of Allergy and Clinical Immunology, 1991
- Allergy-immunology listingsJournal of Allergy and Clinical Immunology, 1991
- Interleukin-1 is released at sites of human cutaneous allergic reactionsJournal of Allergy and Clinical Immunology, 1990
- Soluble CD23 containing B cell supernatants induce IgE from peripheral blood B-lymphocytes and costimulate with interleukin-4 in induction of IgEJournal of Allergy and Clinical Immunology, 1990
- Regulation of human IgE synthesis. I. Human IgE synthesis in vitro is determined by the reciprocal antagonistic effects of interleukin 4 and interferon‐γEuropean Journal of Immunology, 1990
- Induction of human IgE synthesis requires interleukin 4 and T/B cell interactions involving the T cell receptor/CD3 complex and MHC class II antigens.The Journal of Experimental Medicine, 1989
- Modulation of IL‐4‐induced human IgE production in vitro by IFN‐γ and IL‐5: The role of soluble CD23 (s‐CD23)Journal of Cellular Biochemistry, 1989
- Role of Interleukin 4 and Gamma Interferon in the Regulation of Human IgE Synthesis: Possible Alterations in Atopic PatientsInternational Archives of Allergy and Immunology, 1989
- Serum IgE concentration in atopic dermatitis *1Relationship to severity of disease and presence of atopic respiratory diseaseJournal of Allergy and Clinical Immunology, 1974
- IgE in atopic dermatitisArchives of Dermatology, 1971